Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new?
Glucocorticoids (GC) have been used in medicine since the middle of the twentieth century, including for the treatment of various systemic rheumatic diseases. However, long-term use of GC may be accompanied by the development of serious complications, one of which is secondary osteoporosis, leading...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2024-04-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850043084548603904 |
|---|---|
| author | N. V. Toroptsova E. L. Nasonov |
| author_facet | N. V. Toroptsova E. L. Nasonov |
| author_sort | N. V. Toroptsova |
| collection | DOAJ |
| description | Glucocorticoids (GC) have been used in medicine since the middle of the twentieth century, including for the treatment of various systemic rheumatic diseases. However, long-term use of GC may be accompanied by the development of serious complications, one of which is secondary osteoporosis, leading to low-energy fractures, which affects the quality of life of patients and may lead to an increased risk of death. This article presents an overview with a discussion of the new edition of the guideline of the American College of Rheumatology (ACR) 2022 for the prevention and treatment of glucocorticoid-induced osteoporosis in adult patients. |
| format | Article |
| id | doaj-art-3f20c81523fc4bfbb5f09e6d2d848e96 |
| institution | DOAJ |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2024-04-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-3f20c81523fc4bfbb5f09e6d2d848e962025-08-20T02:55:20ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922024-04-0162214515310.47360/1995-4484-2024-145-1532976Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new?N. V. Toroptsova0E. L. Nasonov1V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)Glucocorticoids (GC) have been used in medicine since the middle of the twentieth century, including for the treatment of various systemic rheumatic diseases. However, long-term use of GC may be accompanied by the development of serious complications, one of which is secondary osteoporosis, leading to low-energy fractures, which affects the quality of life of patients and may lead to an increased risk of death. This article presents an overview with a discussion of the new edition of the guideline of the American College of Rheumatology (ACR) 2022 for the prevention and treatment of glucocorticoid-induced osteoporosis in adult patients.https://rsp.mediar-press.net/rsp/article/view/3543glucocorticoidsglucocorticoid-induced osteoporosisfracture riskosteoporosis treatmentguideline |
| spellingShingle | N. V. Toroptsova E. L. Nasonov Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new? Научно-практическая ревматология glucocorticoids glucocorticoid-induced osteoporosis fracture risk osteoporosis treatment guideline |
| title | Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new? |
| title_full | Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new? |
| title_fullStr | Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new? |
| title_full_unstemmed | Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new? |
| title_short | Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new? |
| title_sort | review of 2022 american college of rheumatology acr guideline for the prevention and treatment of glucocorticoid induced osteoporosis what s new |
| topic | glucocorticoids glucocorticoid-induced osteoporosis fracture risk osteoporosis treatment guideline |
| url | https://rsp.mediar-press.net/rsp/article/view/3543 |
| work_keys_str_mv | AT nvtoroptsova reviewof2022americancollegeofrheumatologyacrguidelineforthepreventionandtreatmentofglucocorticoidinducedosteoporosiswhatsnew AT elnasonov reviewof2022americancollegeofrheumatologyacrguidelineforthepreventionandtreatmentofglucocorticoidinducedosteoporosiswhatsnew |